Mr. Travers earned his Bachelor’s degree in Communications from the University of Central Florida. He has started several firms from scratch, including a medical patient education Company that sold training materials to over 3,000 of the nation’s hospitals over a 12-year period. Mr. Travers established a marketing program that achieved over 1,000,000 viewers per year on the closed circuit television systems of over 1000 hospitals nationwide.  

More recently as the president and founder of Comprehensive Loyalty, Inc, Mr. Travers has regularly worked with CEO’s of midsized franchise companies. He has supervised over 400 site selection studies using predictive computer models to determine the best store deployment strategies for individual markets. During his career, Mr. Travers has organized and supervised the completion of over 200,000 consumer surveys, providing marketing assistance to over 50 companies and spoken at association and business meetings.  Mr. Travers has served as the CEO of LifeBridge Innovations, PBC since 2015. He is named on the U.S. Patent for the LB10000 device as a contributing inventor.  

https://www.linkedin.com/in/peterftravers/

https://www.facebook.com/LifeBridge-10000-LLC-416272332060952/

Rick Rotondo currently serves as the Vice President of Corporate Development for LifeBridge Innovations helping to lead the commercialization of its patented Adaptive Tumor Treating Field (ATTF™) technology.

Prior to LifeBridge Innovations Rick was the founder and principal of Chronos Leadership, where he provided one on one and group coaching to mid-level, C-level and founders at start up and not for profit organizations.

Prior to starting his coaching practice, Rick gained over 20 years of marketing and leadership experience from such companies as xG Technology, Motorola, Lucent, Nortel and P&G. Some highlights include: co-founder and Chief Marketing Officer of Spectrum Bridge, Inc. where he was responsible for planning and implementing the company’s marketing and communications strategy. He was also VP of Marketing for MeshNetworks, which he established as distributed wireless networking brand leader before the company was successfully acquired by Motorola in late 2004 for $215M. He previously had served as Marketing Director for Excel Switching, then was promoted to AVP when Excel was acquired by AT&T for $1.7B in 1999.

Rick earned a Professional Coaching Certificate from the University of Miami and an Associate Coaching Certificate from the International Coaching Federation. He holds a BS in Mechanical Engineering from Rensselaer Polytechnic Institute, an MBA from the University of North Carolina at Chapel Hill (awarded one of five full merit scholarships), and a Masters of Telecommunications Management from the University of Dallas (where he was subsequently recruited to become an associate professor).

Rick has served as Scoutmaster for Troop 100 in Oviedo, and actively trains and holds a Black Belt in traditional martial arts.

Mr. Yeh co-founded StemoniX, Inc., a biotechnology company, in April 2014 and served as its Chief Executive Officer and a Board Member through its successful merger with public company Vyant Bio (fka Cancer Genetics) in 2021. Prior to co-founding StemoniX, Mr. Yeh commercialized multiple technologies to the tech industry. Highlights include serving as team lead for the first solid state drive product for Seagate Technology, leading the global partnership between Samsung and Seagate to create new flash technology and program managing the operating system software development for Dell enterprise storage systems. Mr. Yeh has successfully led through a multi-disciplinary approach for the last two decades of career. Mr. Yeh holds a bachelor of science and master’s degree in mechanical engineering (nanotechnology focus) from University of California, San Diego, and a master’s degree in business administration from University of Minnesota’s Carlson School of Management. He has attained professional certifications in program and project management from the Project Management Institute and Mergers and Acquisitions from Northwestern’s Kellogg School of Management. Mr. Yeh serves on the Medical Alley Board of Directors, UC San Diego Alumni Board of Directors and on the board of directors of Oncodea, a cancer diagnostic device company.

https://www.linkedin.com/in/ping-yeh-innovation/

Team leader for development of the LB10000 system and ongoing innovations in the area of Tumor Treating Fields. Mr. Watkins received his B.S.E.E. and M.S.E.E. from the University of New Mexico. He has over 40 years’ experience in developing new high-tech products. He held the position of Electrical Engineering Manager at Northrop Grumman Corp, where he was responsible for overseeing the work of 30 electrical engineers. Mr. Watkins carries top-secret clearance and worked on the Trident Missile while at Gulton Industries. He has also written a book on how to convert gas-powered vehicles to all electric. Mr. Watkins brings a wealth of experience and team-building knowledge to LifeBridge.

https://www.linkedin.com/in/ken-watkins-b1a92660/

Consults on the LB10000 prototype design and ongoing innovations in the area of Tumor Treating Fields. Mr. VanderMey earned his B.S degree in Mechanical Engineering from Geneva College with Math and Electrical Engineering minors. He is the founder and president of Proton Design, a firm that provides engineering design consulting. He led a 15-member engineering department while with the Intellon Corporation. His work has achieved many patents for both him and his clients. He recently designed a medical device to measure pressure during tracheal intubation. Mr. VanderMey developed the original design for the LB10000.

Ms. LaTour has been successful in starting and building new ventures, repositioning under-performing organizations, identifying and negotiating mergers and acquisitions for successful companies, and restarting failing businesses. She currently serves as an Operating Partner for LFE Capital, Naples, FL and Minneapolis, MN and the Managing Partner of LaTour & Associates, an international consulting firm focused on innovative business development. Previously she served as President & CEO of World Telehealth Corporation, an online healthcare company serving the G77 countries; CEO of ContourPak International, a cold therapy healthcare products company (acquired by Futuro); Founder, CEO and President of Theranetics, Inc., a physical therapy media products company (acquired by Kaiser Permanente); President & CEO of numerous tech companies. Ms. LaTour currently serves as Chairman of the Board, Earthrise Space Inc.; Board Member of Zuke Music Inc.; and Karman Space Inc.; and Board Observer for TAO Connect Inc., and Mend Software Inc. She also serves on community boards at Crummer Business School Entrepreneurial Program at Rollins College; the Regional Joint Partnership Capital Task Force for Orlando, Inc., and BizLife and Factur. Ms. LaTour holds a B.S. in Mathematics from University of California, Los Angeles, M.S. degrees in Mathematics & Behavioral Psychology from University of Southern California, and is a graduate of the Advanced Management Program at Harvard University.

https://www.linkedin.com/in/dianalatour/

Mr. Hubbard provides advice on most aspects of LifeBridge’s business model and research efforts. He provides business contacts and will play a major role in advising the structure and organization of the Phase 1 clinical trial. Scott has over 20 years’ experience in the medical device industry. He is presently the Senior Director of Business Development/Partnerships for Merge eClinical, an IBM Company that streamlines data collection and analysis for clinical trials globally. Prior to his present position, he was the Director of Business Development, Medical Devices and Diagnostic Research for ICON plc, the fifth largest clinical research company in the world, with over 10,000 employees in 38 countries.

https://www.linkedin.com/in/scott-hubbard-22998b13/

Dr. Lee Zehngebot has served as the Director of Clinical Research, Florida Hospital Cancer Institute in Orlando since 2007 and has participated as Principal Investigator and Co-Investigator on numerous clinical studies. In 2008, he helped Florida Hospital to earn a Clinical Trials Participation National Award from the American Society of Clinical Oncology (ASCO).Published in prestigious journals such as the Journal of Clinical Oncology, Cancer and Annals of Oncology; recognized with a regional award as one of the Best Doctors in America. Dr. Zehngebot has expressed an interest in being the principle investigator for our phase 1 clinical trial once FDA requirements have been met.

Mr. Krywick earned his B.S.E.E. from the University of Central Florida. His nearly 30 years of experience includes commercial and DoD image processing, command and control, and deeply embedded processing.  Over his career at Martin Marietta, Lockheed, Coleman Research, Teranex, and Northrup Grumman, Mr. Krywick has detected weld flaws in x-ray images of the space shuttle fuel tank, identified helicopters based on temporal features in infra-red video, detected buried land mines from the ground and air, created user and programming interfaces to a high definition converter product line, and integrated lasers and celestial object tracking to guide munitions to ground coordinates reducing collateral damage. Mr. Krywick won a technical Emmy award for his work on High Definition video imaging. Mr. Krywick loves a challenge and brings diverse experience to the LifeBridge Innovations development team.

Duties: Software engineering including integration, communication, operation, worldwide status and upgrade.